Before any telehealth platform can legally prescribe a GLP-1 medication like Ozempic, Wegovy, Mounjaro, or Zepbound, it must confirm you are who you say you are and that a licensed clinician has reviewed your health information. Most platforms use a layered process — government ID scan, photo match, medical intake, and prescriber review — that typically takes minutes to complete online but carries real legal and clinical weight.

Why Does Identity Verification Matter for GLP-1 Prescriptions?

GLP-1 medications are controlled in terms of how they are prescribed and dispensed, even if they are not classified as controlled substances. Under the Ryan Haight Online Pharmacy Consumer Protection Act (2008), any prescriber who writes a prescription without a valid patient-prescriber relationship — including confirming the patient's identity — can face federal penalties. For telehealth specifically, the DEA has issued guidance requiring that platforms establish a legitimate medical relationship before issuing prescriptions.

Beyond legal compliance, identity verification protects you. It prevents someone else from obtaining medication in your name, ensures your medical history is attached to the right person, and helps pharmacies confirm that the prescription is authentic before dispensing an injectable medication.

What Are the Main Steps Telehealth Platforms Use to Verify You?

While every platform differs slightly, the following steps are standard across major GLP-1 telehealth providers:

  • Government-issued photo ID scan: You upload a photo of your driver's license, state ID, or passport. Automated software checks that the document is unaltered and matches formatting standards for the issuing state or country.
  • Selfie or live photo match: You take a real-time selfie that the platform's software compares to the face on your ID using biometric facial recognition. This step confirms the person holding the ID is actually you.
  • Date of birth and personal detail confirmation: You manually enter details that must match your uploaded ID exactly, adding a human-readable layer on top of the automated check.
  • Medical intake questionnaire: You complete a structured health history — weight, height, current medications, diagnoses, and any contraindications relevant to GLP-1 therapy. This is reviewed by a licensed clinician, not just software.
  • Prescriber review and synchronous or asynchronous consultation: A state-licensed physician, nurse practitioner, or physician assistant reviews your intake. Some platforms require a live video call; others use asynchronous review where the clinician assesses your file and responds within hours.
  • Pharmacy identity check: When your prescription is sent to the dispensing pharmacy, the pharmacy independently verifies your name, date of birth, and address before shipping or dispensing the medication.

Most important point: A licensed clinician — not just an algorithm — must review your medical information and approve your prescription before any legitimate telehealth platform sends a GLP-1 order to a pharmacy. If a platform skips this step, it is operating outside federal guidelines.

How Does the Verification Timeline Work?

The table below shows a typical sequence from sign-up to medication shipment on a telehealth GLP-1 platform.

Step What Happens Typical Timeframe
Account creation Email and phone number verified via one-time code Under 5 minutes
ID upload and selfie match Document scan and biometric facial comparison run automatically 2–10 minutes
Medical intake form You complete health history, medication list, and symptom questionnaire 10–20 minutes
Clinician review Licensed provider reviews your file; may send follow-up questions Same day to 48 hours
Prescription issued Clinician approves and sends prescription electronically to pharmacy After clinician approval
Pharmacy verification Pharmacy confirms your identity before dispensing 1–3 business days
Medication shipped or dispensed GLP-1 medication sent to your address or ready for pickup 2–7 days after approval

What Technology Do Platforms Use for ID Verification?

Most major telehealth platforms use third-party identity verification services — companies like Persona, Jumio, or Stripe Identity — that specialize in document authentication and biometric matching. These services apply several checks simultaneously:

  • Optical character recognition (OCR) extracts data from your ID and checks it against known formatting rules for each document type.
  • Liveness detection confirms your selfie is from a real, live person and not a photo of a photo, which prevents basic spoofing attempts.
  • Database cross-referencing may check your name and date of birth against public records to flag inconsistencies.

According to a 2022 analysis published in the Journal of Medical Internet Research (Kovacs et al.), biometric-plus-document verification reduces identity fraud rates in digital health platforms by a significant margin compared to knowledge-based verification alone (such as security questions).

What Happens If Your Verification Fails?

Verification failures are common and are not always a sign of wrongdoing. Poor lighting, a slightly blurry ID photo, or a name change not yet reflected on your ID can all trigger a flag. Here is what typically happens:

  • You receive an automated prompt to resubmit with better photo quality or a different document.
  • A human reviewer at the platform may step in to assess edge cases — for example, if your legal name differs from the name you use.
  • If the mismatch cannot be resolved, the platform will decline to issue a prescription and may direct you to an in-person provider instead.

Platforms are not required to tell you exactly why verification failed, largely to prevent bad actors from learning how to circumvent the system.

How Do Prescription Monitoring Programs Add Another Layer?

Once a GLP-1 prescription is issued, dispensing pharmacies — including mail-order pharmacies used by telehealth platforms — are connected to Prescription Drug Monitoring Programs (PDMPs), state-run databases that track prescriptions. According to the FDA, PDMPs help pharmacies and prescribers spot duplicate prescriptions or prescriptions that conflict with a patient's existing medication profile. While GLP-1 medications are not controlled substances, many pharmacy systems still check PDMP data as part of their standard dispensing workflow, providing an additional identity and safety check at the point of dispensing.

Frequently Asked Questions

Yes. Most telehealth platforms accept any government-issued photo ID, including a U.S. passport, state ID card, or driver's license. Some also accept permanent resident cards. Check the specific platform's accepted document list before starting your intake, since accepted document types vary by provider.
A licensed clinician must review your medical intake before a prescription can be issued — this is a federal requirement under the Ryan Haight Act. The ID verification steps are automated, but the prescribing decision itself must involve a human provider. If a platform claims otherwise, that is a serious red flag.
Reputable platforms use HIPAA-compliant data storage and typically partner with third-party identity verification vendors that are SOC 2 certified, meaning they meet independent security audit standards. Read the platform's privacy policy before submitting your ID to understand how long they retain your document images and biometric data.
You will need to use the name exactly as it appears on your government-issued ID for the verification process. The prescription must be issued in your legal name so the pharmacy can match it to your identity. You can typically note a preferred name separately in your account profile after verification is complete.
Not necessarily. Prescribers must be licensed in the state where the patient is located at the time of the consultation, per both federal and state telehealth laws. Most large platforms have clinicians licensed across many states, but coverage is not always nationwide. You will be asked to confirm your state of residence early in the sign-up process.
The clinical standards are the same — a licensed prescriber must evaluate you and determine that the medication is appropriate. The difference is that telehealth replaces the in-person visit with a digital intake process and remote consultation. Identity verification steps are more formalized in telehealth because the prescriber cannot see your ID in person. The NABP recommends patients use platforms that are verified through its VIPPS or Telehealth accreditation programs.
Avoid platforms that do not require a medical intake form, do not mention a licensed prescriber reviewing your case, offer prescriptions instantly without any wait time, do not ask for a government ID, or advertise medications without any mention of eligibility requirements. The NABP maintains a list of not-recommended online pharmacies at its website that you can check before purchasing.

The identity verification process on telehealth platforms exists to protect you — ensuring that the medication prescribed is appropriate for your specific health profile and that your personal information stays secure. If you have questions about whether a telehealth platform is reputable, or whether a GLP-1 medication is right for your situation, speak with your primary care provider or an endocrinologist before completing any online intake process. They can also help you navigate insurance coverage and monitor your progress once you begin treatment.

Sources
  • Drug Enforcement Administration, "DEA Telemedicine Prescribing Rules", DEA Office of Diversion Control, 2023
  • Ryan Haight Online Pharmacy Consumer Protection Act, U.S. Congress, 2008
  • FDA, "Prescription Drug Monitoring Programs", FDA Drug Safety Communications, 2024
  • Kovacs B et al., "Identity Verification in Digital Health Platforms", Journal of Medical Internet Research, 2022
  • NABP (National Association of Boards of Pharmacy), "Telehealth and Online Pharmacy Standards", NABP Policy Report, 2023

This site provides general information only and does not constitute medical advice. All content is sourced to FDA labeling, NIH publications, or peer-reviewed clinical trials. Always consult your prescriber before making any medication decision.